India is intensifying efforts to address hepatitis and achieve its 2030 goal through the National Viral Hepatitis Control Program. Launched in 2018, this program integrates with other national initiatives to offer free screening, diagnostics, and treatment for citizens infected with hepatitis viruses A, B, C, D, and E.
Under the National Viral Hepatitis Control Program, various strategies are being implemented to raise awareness, enhance access, and provide necessary medical care for those affected by viral hepatitis. The program utilizes a digital portal for patient management and monitoring, focusing on preventive, promotive, and curative interventions.
The government is making significant progress in combating hepatitis A and E, which are typically acute and symptomatic diseases. Through the Integrated Disease Surveillance Program, monitoring and management of these infections are being prioritized. Free diagnostic services and medications are being offered to individuals in need, particularly for hepatitis B and C cases.
Recent data from the 2021 HIV Sentinel Surveillance report revealed that a small percentage of individuals tested positive for hepatitis B and C. The government is advocating for universal screening of pregnant women for hepatitis B as part of reproductive and maternal health initiatives. Additionally, efforts are being made to ensure that all newborns receive the hepatitis B birth dose and immunoglobulin promptly after birth.
To provide comprehensive support and information, the program has a toll-free helpline shared with the NTEP, offering guidance on infection prevention, transmission modes, and available service delivery sites nationwide. The government’s commitment to expanding healthcare services underscores its dedication to combatting hepatitis and improving public health.
